Login / Signup

Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.

Cameron MuraSaskia PreissnerSusanne NahlesMax HeilandPhilip E BourneRobert Preissner
Published in: Signal transduction and targeted therapy (2021)
Keyphrases
  • low dose
  • sars cov
  • cardiovascular events
  • type diabetes
  • cardiovascular disease
  • metabolic syndrome
  • atrial fibrillation
  • insulin resistance
  • acute coronary syndrome
  • glycemic control